PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (28 June 2021)
Question Asked
Asked by:
Sir Alan Campbell (Labour)
Answer
Vaccine responses in individuals in clinical risk groups after one and two doses is being monitored by Public Health England in collaboration with the Royal College of General Practitioners’ Research and Surveillance Centre and data will be published in due course.
Virus Watch, supported by NHS Test and Trace, provides information regarding patients’ antibodies, including immunocompromised patients as part of their cohort. The data suggests some protection against COVID-19 but is only one measure of protection and does not look at cellular immunity which may be more important in terms of long-term immunity.
Answered by:
Nadhim Zahawi (Conservative)
6 July 2021
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.